Dr. Mukund Gurjar

Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer

Eribulin will be available in India at approximately 40% cost of the innovator brand Bengaluru, April 3, 2019: Emcure Pharmaceuticals, a…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420